¼¼°èÀÇ ³ú°Ç° º¸ÃæÁ¦ ½ÃÀå º¸°í¼ : Á¦Ç°, ÇüÅÂ, À¯Åë ä³Î, ¿ëµµ, Áö¿ªº°(2024-2032³â)
Brain Health Supplements Market Report by Product, Form, Distribution Channel, Application, and Region 2024-2032
¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀå ±Ô¸ð´Â 2023³â 62¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC ±×·ìÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 2024-2032³â°£ 7.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î 2032³â±îÁö 126¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.
³ú°Ç° º¸ÃæÁ¦´Â ³ú ±â´ÉÀ» °³¼±Çϱâ À§ÇØ ¼·ÃëÇÏ´Â ´Ù¾çÇÑ Ãµ¿¬ ¹× Çãºê ¿µ¾ç º¸ÃæÁ¦¸¦ ¸»ÇÕ´Ï´Ù. Àλï, ¿¡Å°³×½Ã¾Æ, ÀºÇàÀÙ, Ŀť¹Î, »óȲ¹ö¼¸°ú °°Àº Çãºê ÃßÃâ¹°, Çʼö ºñŸ¹Î, ¾Æ¹Ì³ë»ê, ´Ü¹éÁú, ¹Ì³×¶ö, ¹ÙÀÌ¿ÀÇö󺸳ëÀÌµå µîÀ¸·Î °ÈµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¸ÃæÁ¦´Â Á¤Á¦, ĸ½¶, ¼ÒÇÁÆ®Á©, ºÐ¸», ½Ã·´ µîÀÇ ÇüÅ·Π½ÃÁß¿¡¼ ÆÇ¸ÅµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¸ÃæÁ¦´Â ±â¾ï·Â, ÁýÁß·Â, ÁÖÀÇ·Â, ¼ö¸é ȸº¹, ±âºÐ Á¶Àý, ³ëÈ ¹æÁö, ¿îµ¿ ±â´É °È¿¡ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ³ú°Ç° º¸ÃæÁ¦¸¦ Á¤±âÀûÀ¸·Î ¼·ÃëÇÏ¸é ºÒ¾È, Ä¡¸Å, ¿ì¿ïÁõ, ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹× ±âŸ ½Å°æ ÅðÇ༺ ÁúȯÀÇ ¹ßº´ À§ÇèÀ» ÃÖ¼ÒÈÇÒ ¼ö ÀÖ½À´Ï´Ù.
Àü ¼¼°èÀûÀ¸·Î ½Å°æ ÅðÇ༺ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ Áúº´¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ´ëÁßÀÇ °Ç° ÀνÄÀÌ ³ô¾ÆÁö°í ¹Ù»Û ¾÷¹« ÀÏÁ¤À¸·Î ÀÎÇØ ¼ÒºñÀÚµéÀº Á¤½Å ÁýÁß·ÂÀ» À¯ÁöÇϰí ÇÏ·ç Á¾ÀÏ Àü¹ÝÀûÀÎ ±â´ÉÀ» Çâ»ó½Ã۱â À§ÇØ ³ú°Ç° º¸ÃæÁ¦¸¦ ¸ÅÀÏ ½Ä´Ü¿¡ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¼Ó °¡´ÉÇÑ ¹æ½ÄÀ¸·Î Àç¹èµÈ À¯±â³ó ¿ø·á¸¦ »ç¿ëÇÏ¿© Á¦Á¶µÈ Á¦Ç° Ãâ½Ã¿Í °°Àº ´Ù¾çÇÑ Á¦Ç° Çõ½ÅÀÌ ¶Ç ´Ù¸¥ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀº ¶ÇÇÑ ÀÚ¿¬¿¡¼ ÃßÃâÇÑ °íǰÁú °Ç°±â´É½ÄǰÀÇ ÀÌÁ¡À» ´õ Àß ÀνÄÇϰí ÀÖÀ¸¸ç, ÀÏ»ó ½Ä´Ü¿¡¼ ºÎÁ·ÇÑ ¿µ¾çÀ» º¸ÃæÇϱâ À§ÇØ À̸¦ ³Î¸® »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ±âŸ ¿äÀÎÀ¸·Î´Â ¼ÒºñÀÚÀÇ ÇコÄɾî ÁöÃâ Áõ°¡, ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º» º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®
- 2023³â ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀå ±Ô¸ð´Â?
- 2024-2032³â ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀå ¼ºÀå·ü Àü¸ÁÀº?
- Äڷγª19°¡ ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
- ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀϱî?
- ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀå Á¦Ç°º° ÇöȲÀº?
- ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀåÀÇ Çüź° ºÐ·ù´Â?
- ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀåÀÇ ÆÇ¸Å ä³Îº° ÇöȲÀº?
- ³ú°Ç° º¸ÃæÁ¦ ¼¼°è ½ÃÀå ¿ëµµº° ºÐ·ù´Â?
- ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
- ¼¼°è ³ú°Ç° º¸ÃæÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý
- Á¶»ç ¸ñÀû
- ÀÌÇØ°ü°èÀÚ
- µ¥ÀÌÅÍ ¼Ò½º
- ½ÃÀå ÃßÁ¤
- Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ¼·Ð
Á¦5Àå ¼¼°èÀÇ ³ú°Ç° º¸ÃæÁ¦ ½ÃÀå
- ½ÃÀå °³¿ä
- ½ÃÀå ½ÇÀû
- COVID-19ÀÇ ¿µÇâ
- ½ÃÀå ¿¹Ãø
Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°
- õ¿¬ ºÐÀÚ
- Çãºê ÃßÃâ¹°
- ºñŸ¹Î ¹× ¹Ì³×¶ö
Á¦7Àå ½ÃÀå ºÐ¼® : Çüź°
Á¦8Àå ½ÃÀå ºÐ¼® : À¯Åë ä³Îº°
- ½´ÆÛ¸¶ÄÏ/ÇÏÀÌÆÛ¸¶ÄÏ
- µå·°½ºÅä¾î
- ¿Â¶óÀÎ ½ºÅä¾î
- ±âŸ
Á¦9Àå ½ÃÀå ºÐ¼® : ¿ëµµº°
- ±â¾ï·Â Çâ»ó
- ÁÖÀÇ ¹× ÁýÁß
- ¿ì¿ïÁõ ¹× ±âºÐ
- ¼ö¸é ¹× ȸº¹
- ¾ÈƼ¿¡ÀÌ¡ ¹× Àå¼ö
- ±âŸ
Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°
- ºÏ¹Ì
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- Àεµ³×½Ã¾Æ
- ±âŸ
- À¯·´
- µ¶ÀÏ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ½ÃÀå µ¿Çâ
- ½ÃÀå ºÐ¼® : ±¹°¡º°
- ½ÃÀå ¿¹Ãø
Á¦11Àå SWOT ºÐ¼®
Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®
Á¦13Àå PorterÀÇ Five Forces ºÐ¼®
- °³¿ä
- ¹ÙÀ̾îÀÇ ±³¼··Â
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- °æÀï Á¤µµ
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
Á¦14Àå °¡°Ý ºÐ¼®
Á¦15Àå °æÀï ±¸µµ
- ½ÃÀå ±¸Á¶
- ÁÖ¿ä ±â¾÷
- ÁÖ¿ä ±â¾÷ °³¿ä
- Accelerated Intelligence Inc.
- AlternaScript
- Aurobindo Pharma
- HVMN Inc.
- Liquid Health Inc.
- Natural Factors Nutritional Products Ltd.
- Onnit Labs Inc.
- Purelife Bioscience Co. Ltd.
- Quincy Bioscience LLC
- Reckitt Benckiser Group plc.
- Teva Pharmaceutical Industries Ltd.
LSH
The global brain health supplements market size reached US$ 6.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.
Brain health supplements refer to various natural and herbal dietary compounds consumed to improve brain functioning. They are fortified with herbal extracts, including ginseng, echinacea, ginkgo biloba, curcumin and lion's mane, along with essential vitamins, amino acids, proteins, minerals and bioflavonoids. These supplements are commonly available in the form of tablets, capsules, soft gels, powders and syrups. They aid in enhancing memory, concentration, attention, sleep recovery, mood regulation, aging and motor functions. Regular consumption of brain health supplements also aid in minimizing the risks of developing anxiety, dementia, depression, Alzheimer's and other neurological degenerative disorders.
The increasing prevalence of neurodegenerative disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. With the growing health consciousness among the masses and hectic work schedules, consumers are incorporating brain health supplements into their daily diets to stay mentally alert and improve their overall functioning throughout the day. Additionally, various product innovations, such as the launch of variants manufactured using organic ingredients grown using sustainable methods, are acting as other growth-inducing factors. Consumers are also more aware of the benefits of naturally-sourced high-quality dietary supplements and widely using them to fulfill the nutritional gaps in their regular diets. Other factors, including rising healthcare expenditures of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global brain health supplements market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, form, distribution channel and application.
Breakup by Product:
Natural Molecules
Herbal Extract
Vitamins and Minerals
Breakup by Form:
Tablets and Capsules
Powder
Others
Breakup by Distribution Channel:
Supermarkets and Hypermarkets
Drug Stores
Online Stores
Others
Breakup by Application:
Memory Enhancement
Attention and Focus
Depression and Mood
Sleep and Recovery
Anti-aging and Longevity
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accelerated Intelligence Inc., AlternaScript, Aurobindo Pharma, HVMN Inc., Liquid Health Inc., Natural Factors Nutritional Products Ltd., Onnit Labs Inc., Purelife Bioscience Co. Ltd., Quincy Bioscience LLC, Reckitt Benckiser Group plc. and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report
- 1. What was the size of the global brain health supplements market in 2023?
- 2. What is the expected growth rate of the global brain health supplements market during 2024-2032?
- 3. What has been the impact of COVID-19 on the global brain health supplements market?
- 4. What are the key factors driving the global brain health supplements market?
- 5. What is the breakup of the global brain health supplements market based on the product?
- 6. What is the breakup of the global brain health supplements market based on the form?
- 7. What is the breakup of the global brain health supplements market based on the distribution channel?
- 8. What is the breakup of the global brain health supplements marketbased on the application?
- 9. What are the key regions in the global brain health supplements market?
- 10. Who are the key players/companies in the global brain health supplements market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Brain Health Supplements Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Natural Molecules
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Herbal Extract
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Vitamins and Minerals
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Form
- 7.1 Tablets and Capsules
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Powder
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Supermarkets and Hypermarkets
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Drug Stores
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Application
- 9.1 Memory Enhancement
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Attention and Focus
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Depression and Mood
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Sleep and Recovery
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Anti-aging and Longevity
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
- 9.6 Others
- 9.6.1 Market Trends
- 9.6.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Accelerated Intelligence Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 AlternaScript
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Aurobindo Pharma
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 HVMN Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Liquid Health Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Natural Factors Nutritional Products Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Onnit Labs Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Purelife Bioscience Co. Ltd.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Quincy Bioscience LLC
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Reckitt Benckiser Group plc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Teva Pharmaceutical Industries Ltd.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis